Ashley Magargee, the first woman to be CEO of Genentech, has spent years with the biotech and parent company Roche. This article was originally published in the San Francisco Business Times, an ...

Genentech CEO Alexander Hardy, in an interview with STAT, explained that in the world that existed prior to the Inflation Reduction Act’s passage last year, ...

Before becoming Genentech’s CEO in 2019, Hardy held several senior roles at Roche and Genentech. His experience also includes posts at Novartis, PathoGenesis, and GSK.

In the latest episode of our BioFlash podcast, new Genentech CEO Bill Anderson talks about conquering "immune deserts," annual drug price increases and what those mean for the industry and what ...

No matter what the acquirer says, there's always a big shakeup after a deal goes down. We mention this now because of a statement Roche put out yesterday detailing the new leadership at Genentech ...

Genentech, a leading biotechnology company based in San Francisco, is set to build a $700 million manufacturing plant in Wake County, creating over 400 new jobs, Governor Josh Stein announced Monday.

BioMarin Pharmaceutical longtime CEO J.J. Bienaimé is retiring. The top executive of South San Francisco-based Genentech, which has a major Vacaville facility, is switching jobs to fill that role ...

Genentech will invest $700 million in a new Holly Springs plant, creating 400 jobs. To stream WFMY News 2 on your phone, you need the WFMY News 2 app. Download the WFMY News 2 app ...

Genentech, a leading biotechnology company based in San Francisco, is set to build a $700 million manufacturing plant in Wake County, creating over 400 new jobs, Governor Josh Stein announced Monday.

Genentech plans to invest more than $700 million in a new 700,000-f t 2 drug manufacturing facility in Holly Springs, NC. ... CEO at Genentech. ...